Ryan D. Maynard
2013
In 2013, Ryan D. Maynard earned a total compensation of $1.1M as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 24% decrease compared to previous year.
Compensation breakdown
| Option Awards | $669,900 |
|---|---|
| Salary | $441,345 |
| Other | $780 |
| Total | $1,112,025 |
Maynard received $669.9K in option awards, accounting for 60% of the total pay in 2013.
Maynard also received $441.3K in salary and $780 in other compensation.
Rankings
In 2013, Ryan D. Maynard's compensation ranked 6,138th out of 12,286 executives tracked by ExecPay. In other words, Maynard earned more than 50.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,138 out of 12,286 | 50th |
Division Manufacturing | 2,136 out of 4,612 | 54th |
Major group Chemicals And Allied Products | 634 out of 1,466 | 57th |
Industry group Drugs | 458 out of 1,160 | 61st |
Industry Pharmaceutical Preparations | 366 out of 890 | 59th |
Source: SEC filing on March 28, 2016.
Maynard's colleagues
We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2013.